Share Article
Restart of production in separation plant SP5
23 October 2015 Urenco Nederland NewsToday Urenco Nederland has restarted production capacity that was paused as a result of the incident that took place on 27 August 2015. The investigation into the technical cause of the incident has been concluded and reported to the Authority for Nuclear Safety and Radiation Protection (ANVS). This investigation was conducted by Urenco, under supervision of the ANVS and with input from independent bodies. It has been concluded that the incident was caused by a chemical reaction as a result of a build-up of fluorine in a filter with trapping material. Measures have been implemented in all Urenco’s enrichment plants to prevent reoccurrence. The ANVS has approved restart of production, having taken three aspects into consideration: the investigation into the cause of the incident, the manner in which the consequences have been addressed and the procedure for restarting production. As part of our focus on continual improvement, we will maintain our review of processes and operations on all our sites.
Share Article
About Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries